![]() |
|
|
K Ono, H Nakane, P Herdewijn, J Balzarini and E De Clercq
Laboratory of Viral Oncology, Aichi Cancer Center Research Institute, Nagoya, Japan.
Several analogues of 2',3'-dideoxythymidine 5'-triphosphate [i.e., 3'- azido-2', 3'-dideoxythymidine 5'-triphosphate(Azdd TTP), 2',3'- didehydro-2',3'-dideoxythymidine 5'-triphosphate (ddeTTP), alpha, beta- methylene 3'-azido-2',3'-dideoxythymidine 5'-diphosphate, alpha, beta- methylene 3'-azido-2',3'-dideoxythymidine 5'-triphosphate, and beta, gamma-methylene 3'-azido-2',3'-dideoxythymidine 5'-triphosphate] and 2',3'-didehydro-2',3'-dideoxycytidine 5'-triphosphate (ddeCTP) have been evaluated for their inhibitory effects on murine retroviral reverse transcriptase and various other DNA polymerases, including DNA polymerases alpha, beta, and gamma, terminal deoxynucleotidyl transferase, and DNA polymerase I. None of the compounds inhibited the activity of DNA polymerase alpha under the reaction conditions employed. When Mg2+ was replaced by Mn2+, however, DNA polymerase alpha was strongly inhibited only by ddeTTP. DNA polymerase beta activity was inhibited only by ddeTTP and ddeCTP. All the compounds, except for ddeCTP, inhibited DNA polymerase gamma activity, ddeTTP being a particularly strong inhibitor of gamma-polymerase (Ki = 3.5 nM). Terminal deoxynucleotidyl transferase was only slightly inhibited by any of the compounds. AzddTTP was a potent inhibitor of reverse transcriptase (Ki = 42 nM), but it also inhibited the activities of DNA polymerase gamma and DNA polymerase I.
This article has been cited by other articles:
![]() |
L D Lewis, S Amin, C I Civin, and P S Lietman Ex vivo zidovudine (AZT) treatment of CD34+ bone marrow progenitors causes decreased steady state mitochondrial DNA (mtDNA) and increased lactate production Human and Experimental Toxicology, April 1, 2004; 23(4): 173 - 185. [Abstract] [PDF] |
||||
![]() |
B. Schneider, R. Biondi, R. Sarfati, F. Agou, C. Guerreiro, D. Deville-Bonne, and M. Veron The Mechanism of Phosphorylation of Anti-HIV D4T by Nucleoside Diphosphate Kinase Mol. Pharmacol., May 1, 2000; 57(5): 948 - 953. [Abstract] [Full Text] |
||||
![]() |
M. Kukhanova, X. Li, S.-H. Chen, I. King, T. Doyle, W. Prusoff, and Y.-C. Cheng Interaction of beta -L-2',3'-dideoxy-2',3'-didehydro-5-fluoro-CTP with Human Immunodeficiency Virus-1 Reverse Transcriptase and Human DNA Polymerases: Implications for Human Immunodeficiency Virus Drug Design Mol. Pharmacol., May 1, 1998; 53(5): 801 - 807. [Abstract] [Full Text] |
||||